Cetirizine Hydrochloride
- Product NDC
- 53002-1259
- 11-digit product format
- 530021259
- Labeler code
- 53002
- Product ID
- 53002-1259_880775db-061e-4282-bc19-fe651dd86ce3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA077829
- Marketing category
- ANDA
- Marketing start
- 2009-10-01
- Marketing end
- 0000-00-00
- Substance
- CETIRIZINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1259-0 | 53002125900 | 100 TABLET in 1 BOTTLE (53002-1259-0) | 100 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |
| 53002-1259-1 | 53002125901 | 10 TABLET in 1 BOTTLE (53002-1259-1) | 10 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |
| 53002-1259-2 | 53002125902 | 20 TABLET in 1 BOTTLE (53002-1259-2) | 20 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |
| 53002-1259-3 | 53002125903 | 30 TABLET in 1 BOTTLE (53002-1259-3) | 30 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |
| 53002-1259-9 | 53002125909 | 5 TABLET in 1 BOTTLE (53002-1259-9) | 5 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |